City

Bethesda (2)

Condition

Chronic GVHD (2)

Immune Mediated Anemia (2)

Immune Mediated Thrombocytopenia (2)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI) (2)

Collaborator

Intervention

fostamatinib (2)

Study Documents

Intervention Type

drug (2)

Funder Type

NIH (2)

Study Type

Interventional (2)

immune mediated thrombocytopenia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting

Immune Mediated Anemia
+2 more

fostamatinib

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 24, 2022

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting

Immune Mediated Anemia
+2 more

fostamatinib

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 17, 2022